Ventilator-associated pneumonia is an important cause of nosocomial complications. This large, multicenter study compared the usefulness in guiding therapy of two diagnostic approaches for ventilator-associated pneumonia: bronchoalveolar lavage with quantitative culture and endotracheal aspiration with nonquantitative culture. Clinical outcomes such as the 28-day mortality rate and overall use of antimicrobial agents were similar with the two strategies.

In an analysis from the Framingham Heart Study, 10 biomarkers were evaluated for their ability to predict clinical outcomes. The addition of biomarkers to conventional risk factors resulted in significant increases in the hazard ratios for death and major cardiovascular events but only small increases in the C statistic for each end point. The incremental value of the assessment of biomarkers to the evaluation of established risk factors appears to be modest.

With the availability of cefotetan and cefoxitin possibly ending, effective agents for wound prophylaxis during elective colorectal surgery are needed. In this large randomized, multicenter, double-blind study, ertapenem was found to be superior to cefotetan in the prevention of surgical-site infection but was associated with an increase in Clostridium difficile infection.

A small molecule (FDDNP) that binds amyloid senile plaques and tau neurofibrillary tangles (the neuropathological findings in Alzheimer's disease) was injected into subjects before PET scanning. FDDNP binding was highest in subjects with Alzheimer's disease, intermediate in those with mild cognitive impairment, and lowest in normal controls. Whether there will be clinical applications for this noninvasive method of detecting cerebral plaques and tangles is not known.